Key Documents
Sandhya Srinivas
Academic Appointments
- Associate Professor - Med Center Line, Medicine - Oncology
- Member, Cancer Center
Contact Information
-
Clinical Offices
Uro-Oncology Clinic 875 Blake Wilbur Dr Clinic E Stanford, CA 94305-5826 Tel Work (650) 498-6000 Fax (650) 736-1640
Professional Snapshot
Clinical Focus
- Cancer > Urologic Oncology
- Bladder Cancer
- Bladder Cancer - Medical Oncology
- Germ Cell Tumors
- Germ Cell Tumors - Medical Oncology
Professional Education
| Fellowship: | UCSF Medical Center, CA (1994) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1992) |
| Residency: | St. Mary's Hospital - New York, NY (1991) |
| Internship: | St. Mary's Hospital - New York, NY (1991) |
| Medical Education: | Madras Medical College Hospitals, India (1985) |
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | Bayer, Pfizer |
Scientific Focus
Research Interests
The Genito-Urinary Multidisciplinary tumor board at Stanford specalizes in taking care of patients with prostate cancer, renal cancer, testicular and bladder cancer. Patients are seen at different stages of their tumor. A multisdiscplinary approach is used. A variety of clinical trials are available to patients. Phase II trials using unique combination of chemotherapy agents, antiangiogenic drugs, novel agents are being explored.Co-operative group particpation through ECOG is also available
Clinical Trials
- A Phase 1 Study of an Oral VEGFR Inhibitor (AV-951) in Combination With Torisel in Renal Cell Cancer Recruiting
- AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer Recruiting
- Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer Recruiting
- Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer Recruiting
- Phase III Study of Aflibercept vs Placebo for Metastatic Androgen-Independent Prostate Cancer Recruiting
Publications
- Combination therapy with calcitriol and non-steroidal anti-inflammatory drugs in the treatment of prostate cancer Dermato Endocrinolgy. 2009: 7-11
- High-dose chemotherapy followed by stem cell rescue for high-risk germ cell tumors: the Stanford experience. Bone Marrow Transplant. 2009; (7): 547-52
- Laparoscopic radical nephrectomy after shrinkage of a caval tumor thrombus with sunitinib. Nat Rev Urol. 2009; (6): 338-43
- Increased hemoglobin associated with VEGF inhibitors in advanced renal cell carcinoma. Cancer Invest. 2009; (8): 851-6
- A phase II trial of calcitriol and naproxen in recurrent prostate cancer. Anticancer Res. 2009; (9): 3605-10
Trial Administration